Rafik Bekkat-Berkani

1.3k total citations
34 papers, 844 citations indexed

About

Rafik Bekkat-Berkani is a scholar working on Epidemiology, Microbiology and Health. According to data from OpenAlex, Rafik Bekkat-Berkani has authored 34 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 22 papers in Microbiology and 7 papers in Health. Recurrent topics in Rafik Bekkat-Berkani's work include Bacterial Infections and Vaccines (22 papers), Influenza Virus Research Studies (19 papers) and Pneumonia and Respiratory Infections (19 papers). Rafik Bekkat-Berkani is often cited by papers focused on Bacterial Infections and Vaccines (22 papers), Influenza Virus Research Studies (19 papers) and Pneumonia and Respiratory Infections (19 papers). Rafik Bekkat-Berkani collaborates with scholars based in United States, Belgium and France. Rafik Bekkat-Berkani's co-authors include Gaël Dos Santos, Rino Rappuoli, Mariagrazia Pizza, Muhamed‐Kheir Taha, Bruce L. Innis, Véronique Abitbol, T. Mark Doherty, Federico Martinón‐Torres, Nadia Meyer and Philippe Buchy and has published in prestigious journals such as BMC Public Health, Vaccine and The Pediatric Infectious Disease Journal.

In The Last Decade

Rafik Bekkat-Berkani

34 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafik Bekkat-Berkani United States 16 603 382 186 136 87 34 844
Nicoline van der Maas Netherlands 19 716 1.2× 467 1.2× 328 1.8× 250 1.8× 31 0.4× 65 1.0k
Berit Feiring Norway 15 782 1.3× 433 1.1× 242 1.3× 124 0.9× 37 0.4× 38 1.0k
Carey R. Petrie United States 7 381 0.6× 248 0.6× 246 1.3× 103 0.8× 24 0.3× 9 567
Stephanie Jones South Africa 14 499 0.8× 94 0.2× 169 0.9× 218 1.6× 51 0.6× 23 779
Sarah S. Long United States 12 835 1.4× 141 0.4× 107 0.6× 221 1.6× 204 2.3× 22 1.0k
María Garcés‐Sánchez Spain 14 625 1.0× 222 0.6× 140 0.8× 179 1.3× 86 1.0× 66 756
Hanna Czajka Poland 12 478 0.8× 249 0.7× 121 0.7× 119 0.9× 46 0.5× 45 612
Polly Burbidge United Kingdom 13 1.1k 1.8× 500 1.3× 84 0.5× 83 0.6× 37 0.4× 20 1.1k
ChrisAnna M. Mink United States 16 857 1.4× 801 2.1× 90 0.5× 176 1.3× 56 0.6× 27 1.0k
Joan Bartlett United States 13 946 1.6× 757 2.0× 257 1.4× 231 1.7× 29 0.3× 21 1.1k

Countries citing papers authored by Rafik Bekkat-Berkani

Since Specialization
Citations

This map shows the geographic impact of Rafik Bekkat-Berkani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafik Bekkat-Berkani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafik Bekkat-Berkani more than expected).

Fields of papers citing papers by Rafik Bekkat-Berkani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafik Bekkat-Berkani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafik Bekkat-Berkani. The network helps show where Rafik Bekkat-Berkani may publish in the future.

Co-authorship network of co-authors of Rafik Bekkat-Berkani

This figure shows the co-authorship network connecting the top 25 collaborators of Rafik Bekkat-Berkani. A scholar is included among the top collaborators of Rafik Bekkat-Berkani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafik Bekkat-Berkani. Rafik Bekkat-Berkani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bekkat-Berkani, Rafik, et al.. (2024). The Diverse Spectrum of Invasive Meningococcal Disease in Pediatric and Adolescent Patients: Narrative Review of Cases and Case Series. Infectious Diseases and Therapy. 13(2). 251–271. 2 indexed citations
2.
3.
Bekkat-Berkani, Rafik, et al.. (2023). Determinants of Meningococcal Vaccination Coverage and Adherence: A Targeted Literature Review Supporting a 16-year-old Healthcare Visit. Infectious Diseases and Therapy. 12(5). 1265–1282. 5 indexed citations
4.
Marshall, Gary S., Victoria Abbing‐Karahagopian, Helen Marshall, et al.. (2023). A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB). Expert Review of Vaccines. 22(1). 530–544. 13 indexed citations
5.
Taha, Muhamed‐Kheir, Rafik Bekkat-Berkani, & Véronique Abitbol. (2023). Changing patterns of invasive meningococcal disease and future immunization strategies. Human Vaccines & Immunotherapeutics. 19(1). 2186111–2186111. 12 indexed citations
6.
Nautrup, B Poulsen, Ruprecht Schmidt‐Ott, Martin Eichner, et al.. (2022). Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany. Human Vaccines & Immunotherapeutics. 18(5). 2058304–2058304. 5 indexed citations
7.
Taha, Muhamed‐Kheir, Federico Martinón‐Torres, Paolo Bonanni, et al.. (2022). Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease. Expert Review of Vaccines. 21(5). 659–674. 24 indexed citations
8.
Shen, Jing, et al.. (2022). Range of invasive meningococcal disease sequelae and health economic application – a systematic and clinical review. BMC Public Health. 22(1). 1078–1078. 37 indexed citations
9.
Bekkat-Berkani, Rafik, et al.. (2022). Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB. Journal of Infection. 85(5). 481–491. 12 indexed citations
10.
Martinón‐Torres, Federico, Muhamed‐Kheir Taha, Markus Knuf, et al.. (2021). Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations. Pathogens and Global Health. 116(2). 85–98. 29 indexed citations
11.
Martinón‐Torres, Federico, Angelika Banzhoff, Chiara Azzari, et al.. (2021). Avances recientes en la prevención de la enfermedad meningocócica B: evidencia real de la vacunación con 4CMenB. Vacunas. 22(3). 189–202. 2 indexed citations
12.
Seib, Kate L., Muhamed‐Kheir Taha, Julio A. Vázquez, et al.. (2021). Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect. npj Vaccines. 6(1). 130–130. 40 indexed citations
13.
Abitbol, Véronique, et al.. (2021). Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination. Infectious Diseases and Therapy. 10(4). 1949–1988. 18 indexed citations
14.
Beck, Ekkehard, Véronique Abitbol, Örjan Åkerborg, et al.. (2020). Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England. Vaccine. 38(47). 7558–7568. 19 indexed citations
15.
Pizza, Mariagrazia, Rafik Bekkat-Berkani, & Rino Rappuoli. (2020). Vaccines against Meningococcal Diseases. Microorganisms. 8(10). 1521–1521. 89 indexed citations
16.
Schmidt‐Ott, Ruprecht, Emad Yanni, Rafik Bekkat-Berkani, et al.. (2019). Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations. Human Vaccines & Immunotherapeutics. 16(4). 836–845. 6 indexed citations
17.
Vojtek, Ivo, Ilse Dieussaert, T. Mark Doherty, et al.. (2018). Maternal immunization: where are we now and how to move forward?. Annals of Medicine. 50(3). 193–208. 91 indexed citations
18.
Santos, Gaël Dos, Philip O. Buck, Carine Claeys, et al.. (2017). A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Human Vaccines & Immunotherapeutics. 13(7). 1640–1652. 47 indexed citations
19.
Bekkat-Berkani, Rafik, Tom Wilkinson, Philippe Buchy, et al.. (2017). Seasonal influenza vaccination in patients with COPD: a systematic literature review. BMC Pulmonary Medicine. 17(1). 79–79. 93 indexed citations
20.
Santos, Gaël Dos, Elisabeth Neumeier, & Rafik Bekkat-Berkani. (2015). Influenza: Can we cope better with the unpredictable?. Human Vaccines & Immunotherapeutics. 12(3). 699–708. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicoline van der Maas Breakdown of academic impact, for papers by Berit Feiring Breakdown of academic impact, for papers by Carey R. Petrie Breakdown of academic impact, for papers by Stephanie Jones Breakdown of academic impact, for papers by Sarah S. Long Breakdown of academic impact, for papers by María Garcés‐Sánchez Breakdown of academic impact, for papers by Hanna Czajka Breakdown of academic impact, for papers by Polly Burbidge Breakdown of academic impact, for papers by ChrisAnna M. Mink Breakdown of academic impact, for papers by Joan Bartlett
Rankless by CCL
2026